	When to assess responses to treatments in adaptive interventions? An experimental analysis of assessment timing in a smoking cessation treatment in the context of lung cancer screening. Nicotine Tob Res Horii RI, Rothman AJ, Vock DM, Joseph AM, Branson M, Melzer AC, Begnaud A, Fu SS. PMID: 41626753 [PubMed - as supplied by publisher]
	Four New Perforane-Type Sesquiterpenes from Laurencia obtusa (Hudson) J.V. Lamouroux as Potent Lung Cancer Inhibitors: Isolation, Structure Elucidation, Cytotoxicity, Molecular Docking, Dynamics, and ADME Studies. ACS Omega Demirk, , Elçi Y, Co, Alim Toraman GÖ, Erol E, Okudan E, Topçu G. PMID: 41626507 [PubMed]
	Projecting future mortality risk of pleural mesothelioma in Italy (2020-2034): Bayesian age-period-cohort analysis over 40â€¯years of death registration. Front Public Health Sartore A, Stoppa G, Minelli G, Mensi C, Consonni D, Manno V, Marinaccio A, Fazzo L, Biggeri A, Catelan D. PMID: 41626351 [PubMed - indexed for MEDLINE]
	Radiomics-based optimization of target selection in CT-guided percutaneous lung cancer biopsy: a retrospective study. Front Oncol Wang J, Zhang Z, Liu X, Wang X, Chen Y, Liu J. PMID: 41626154 [PubMed]
	Traditional Chinese medicine for non-small cell lung carcinoma: An evidence mapping. Integr Med Res Dai Z, Chen X, Li N, Tan C, Zhang Y, Wang Y, Zhao R, Li K, Clarke M, Liu L, Chen L. PMID: 41626135 [PubMed]
	Effect of preoperative inspiratory muscle training combined with education course on postoperative pulmonary complications in high-risk patients with lung cancer after video-assisted thoracoscopic surgery: a randomized controlled trial. Contemp Clin Trials Commun Lu T, Shi Z, Huang S, Lv L, Chen X, Ma K, Li X, Lai F, Ni J. PMID: 41626065 [PubMed]
	Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial. Asia Pac J Oncol Nurs Luo Y, Cheng Y, Song Z, Chen H, Bo Y, Shixing H. PMID: 41625083 [PubMed]
	Lung cancer immunotherapy in 2025: where we stand and what comes next? Front Immunol Han J, Yang Z, Zhao H. PMID: 41624891 [PubMed - indexed for MEDLINE]
	Multi-omics integration and machine learning identify NPC2 as a prognostic and treatment-responsive regulator in lung adenocarcinoma. Front Immunol Li A, Cui P, Liu L, Liu J, Zhou X, Wu W, Yan Z, Guan Y, Zhang H. PMID: 41624864 [PubMed - indexed for MEDLINE]
	The needs and expectations of people eligible for lung cancer screening in Switzerland: A mixed method study. Prev Med Rep Schindler M, Schneider C, von Garnier C, Bongard C, Bulliard JL, Pozzessere C, Selby K, Akre C. PMID: 41624810 [PubMed]
	Clinically relevant somatic variants and genomic discordance between primary tumors and mediastinal lymph nodes in lung adenocarcinoma. Ther Adv Med Oncol Faria CS, Baldavira CM, Prieto TG, Santoro IL, Figueiredo VR, do Nascimento ECT, Kulikowski LD, Takagaki TY, Cervato M, Terra RM, Capelozzi VL, Antonangelo L. PMID: 41624150 [PubMed]
	Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain. Lancet Reg Health Eur Provencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, López Castro R, Fernández Bruno M, Bernabé R, Bosch-Barrera J, Massutí B, Sánchez A, Ortega AL, Guirado M, Del Barco E, Camps C, Lázaro-Quintela M, Dómine M, Sala MÁ, Medina K, González-Larriba JL, Aparisi F, Oramas J, Aguiar D, Cerezo S, Losada B, Ruano-Ravina A, Cantero A, Ospina-Serrano AV, Calvo V, Spanish Lung Cancer Group (SLCG/GECP)b, Spanish Lung Cancer Group (SLCG/GECP). PMID: 41624086 [PubMed]
	Disentangling Links Between Lung Cancer and Infectious Pneumonia via Real-World Data and Integrative Genomics. Hum Mutat Diao YF, Chen Z, Tang YF, Xie T, Ge QY, Xie K, Cong ZZ, Shen Y, Chen S. PMID: 41624060 [PubMed - indexed for MEDLINE]
	Hepatotoxicity of new-generation ALK inhibitors versus crizotinib in patients with non-small cell lung cancer: A systematic review and meta-analysis. iScience Luo X, Du X, Chen Q, Wang C, Li L, He X, Gong Y, Chen J, Zhong X, Liu Y, Zhang X, Huang L. PMID: 41623453 [PubMed]
	Open-Label Randomized Controlled Study of a Disposable Dry Seal Chest Drainage System for Safety and Efficiency in Lobectomy Patients. Thorac Cancer Liu L, Gao X, Zhang J, Guo C, Chen Y, Huang C, Qian Z, Guo Y, Zhang Y, Li S. PMID: 41622760 [PubMed - indexed for MEDLINE]
	Machine learning-based prognostic model for local control prediction in lung cancer patients undergoing stereotactic body radiation therapy: a preliminary study. Eur J Med Res Huang BT, Lin PX, Wang Y, Luo LM. PMID: 41622255 [PubMed - as supplied by publisher]
	Multiomics analysis reveals that senescent CXCL16(+) macrophages promote lung adenocarcinoma progression through TGF-Î² signalling. J Transl Med Zhang ZH, Yin JZ, Li W, Xiao H, Wang D, Yang MH. PMID: 41622242 [PubMed - as supplied by publisher]
	Multi-omics integration in deciphering non-small cell lung cancer drug resistance: current status, challenges, and future prospects. Hereditas Miao J, Guan W, Wang J, Gong H, Xie Q, Gao Y. PMID: 41622239 [PubMed - indexed for MEDLINE]
	Pulmonary origin and risk assessment of cancer-associated thrombosis. Thromb J Sun H, Zhai Q, Xin B, Zhong L, Shi K. PMID: 41622206 [PubMed - as supplied by publisher]
	Prognostic factors in early-stage lung adenocarcinoma: a multicenter study prognostic markers in early lung adenocarcinoma. J Cardiothorac Surg Özç, Yamansavc, Sezen CB, Kizir D, Saydam Ö, Turna A. PMID: 41622192 [PubMed - as supplied by publisher]

Articles 1 - 20 / 156894

Page 1 of 7845



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy